Weekly Paclitaxel Liposome Injection Plus Cisplatin in Preoperative Treatment of Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pathological complete response (pCR) rate in
breast cancer patients treated with weekly paclitaxel liposome injection plus cisplatin
preoperative regimen.